Literature DB >> 16024828

Fluid overload contributing to heart failure.

Avraham Shotan1, Samir Dacca, Michael Shochat, Marc Kazatsker, David S Blondheim, Simcha Meisel.   

Abstract

BACKGROUND: In advanced heart failure, the compensatory responses to reduced cardiac output, in spite of fluid retention, lead to maladaptive consequences.
METHODS: We performed a Medline survey for fluid overload and heart failure as well as reviewing textbook chapters.
RESULTS: The increased sympathetic nervous system, renin-angiotensin-aldosterone system, and antidiuretic hormone stimulation and release lead to a vicious cycle--augmenting pre-load, contractility and after-load, as well as increased fluid overload. The elevated work load on an already failed cardio-circulatory system results in further deterioration. Plasma volume is usually increased in untreated patients with increased extracellular fluid. However, it may range from reduced to increased in treated patients. Currently, diuretics remain the initial first line of therapy. In refractory cases, restoring plasma volume and osmolality, by adding albumin or hypertonic saline solutions, neurohormonal antagonists such as vasopressin receptors antagonists, aldosterone antagonists, or administration of nesiritide, may help in overcoming fluid overload.
CONCLUSION: Exact measurement of plasma volume in various forms of heart failure and adjusting the treatment accordingly, establishing favourable and detrimental effects of various therapies, and introducing additional and new therapeutic options require further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024828     DOI: 10.1093/ndt/gfh1103

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Hospital treatment for fluid overload in the Medicare hemodialysis population.

Authors:  Thomas J Arneson; Jiannong Liu; Yang Qiu; David T Gilbertson; Robert N Foley; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 8.237

2.  Fluid overload in infants following congenital heart surgery.

Authors:  Matthew A Hazle; Robert J Gajarski; Sunkyung Yu; Janet Donohue; Neal B Blatt
Journal:  Pediatr Crit Care Med       Date:  2013-01       Impact factor: 3.624

3.  Population pharmacokinetics of serelaxin in patients with acute or chronic heart failure, hepatic or renal impairment, or portal hypertension and in healthy subjects.

Authors:  Antoine Soubret; Yinuo Pang; Jing Yu; Marion Dahlke
Journal:  Br J Clin Pharmacol       Date:  2018-08-23       Impact factor: 4.335

4.  Comparison of hydration and nutritional status between young and elderly hemodialysis patients through bioimpedance analysis.

Authors:  Jung Eun Lee; In Young Jo; Song Mi Lee; Woo Jeong Kim; Hoon Young Choi; Sung Kyu Ha; Hyung Jong Kim; Hyeong Cheon Park
Journal:  Clin Interv Aging       Date:  2015-08-13       Impact factor: 4.458

5.  A Clinically Relevant Functional Model of Type-2 Cardio-Renal Syndrome with Paraventricular Changes consequent to Chronic Ischaemic Heart Failure.

Authors:  Joanne Clare Harrison; Scott Duncan George Smart; Emma Maria Hinemoa Besley; Jessica Renee Kelly; Morgayn Iona Read; Yimin Yao; Ivan Andrew Sammut
Journal:  Sci Rep       Date:  2020-01-27       Impact factor: 4.379

6.  ß-2 microglobulin level is negatively associated with global left ventricular longitudinal peak systolic strain and left atrial volume index in patients with chronic kidney disease not on dialysis.

Authors:  Akar Yılmaz; Banu Yılmaz; Selçuk Küçükseymen
Journal:  Anatol J Cardiol       Date:  2016-03-23       Impact factor: 1.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.